|

NK cell therapy Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • Marzieh Ebrahimi1

Indications

  • High Grade Glioma (III or IV)1
  • Glioma Glioblastoma Multiforme1
  • Cancer1

Other1 trial

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.